Schizophrenia & Other Psychotic Disorders
Pearls
Is it adolescent psychosis? Consider these 6 issues
Evidence-Based Reviews
Switching antipsychotics: A balanced approach to ease the transition
With no standards or guidelines, you’re working without a net. Here’s evidence you need to hone your clinical judgment and help patients switch...
Cases That Test Your Skills
Clozapine therapy: Timing is everything
After numerous failed, trials Ms. G’s schizophrenia responds only to clozapine. Her white blood cell count slips dangerously low, but stopping the...
Cases That Test Your Skills
Treating schizophrenia in the ‘real world’
Mr. F—with a history of severe motor effects and noncompliance—seems ‘damned’ to a life of delusional, violent behavior. After 17 years of...
Evidence-Based Reviews
How to avoid ethnic bias when diagnosing schizophrenia
Is your practice bias-free? Examining the misdiagnosis of African-Americans yields insights into how to avoid cultural misunderstandings.
Evidence-Based Reviews
Irritable bowel syndrome and psychiatric illness: Three clinical challenges
Target specific symptoms, consider possible drug-drug interactions, and watch for underlying life-threatening complications.
Pearls
Taking the ‘ouch’ out of IM antipsychotics
From the Editor
First-episode psychosis: our greatest challenge
Out Of The Pipeline
Aripiprazole: What the researchers say
Aripiprazole has demonstrated efficacy in schizophrenia, with fewer and less-severe side effects than older antipsychotics. Here are evidence-...
Evidence-Based Reviews
First psychotic episode—a window of opportunity: Seize the moment to build a therapeutic alliance
Intervening early and building a therapeutic alliance can improve medication adherence, reduce relapse risk, and favorably alter the course of...
Evidence-Based Reviews
UPDATE ON ATYPICALS: Practical tips to manage common side effects
Using these agents to their greatest advantage requires careful clinical monitoring to prevent their potential disadvantages.